Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$40.25 - $52.99 $40,250 - $52,990
-1,000 Reduced 3.85%
25,000 $1.04 Million
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $10.2 Million - $11.6 Million
-213,000 Reduced 89.12%
26,000 $1.41 Million
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $489,647 - $584,285
10,100 Added 4.41%
239,000 $12.3 Million
Q3 2023

Nov 09, 2023

BUY
$57.89 - $64.73 $694,680 - $776,760
12,000 Added 5.53%
228,900 $13.3 Million
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $2.01 Million - $2.23 Million
31,500 Added 16.99%
216,900 $13.9 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $13.5 Million - $15.3 Million
-205,200 Reduced 52.53%
185,400 $12.9 Million
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $17.2 Million - $20.4 Million
-251,600 Reduced 39.18%
390,600 $28.1 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $55,666 - $32.9 Million
428,200 Added 200.09%
642,200 $45.7 Million
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $44.4 Million - $48.9 Million
-610,800 Reduced 74.05%
214,000 $16.5 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $8.59 Million - $10.3 Million
139,800 Added 20.41%
824,800 $60.2 Million
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $9.1 Million - $10.6 Million
169,700 Added 32.93%
685,000 $42.7 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $30.5 Million - $35.7 Million
515,300 New
515,300 $30.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.